M. Kathryn (Kathy) Liszewski

Research output

Research output per year 1976 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2019 2020 2022 2023 2025

• 209 Article
• 25 Review article
• 18 Short survey
• 12 Comment/debate
• 7 More
  • 3 Chapter
  • 3 Editorial
  • 1 Letter

Research output per year

Research output per year

Search results

• 2025

  Optimizing AAV Gene Delivery Hitting the Target Safely and Effectively: Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies

  Liszewski, K., Feb 1 2025, In: Genetic Engineering and Biotechnology News. 45, 2, p. 16-19 4 p.

  Research output: Contribution to journal › Article › peer-review
• 2024

  Cancer Genomics Aims to See All, Know All, Inform All

  Liszewski, K., Mar 1 2024, In: Genetic Engineering and Biotechnology News. 44, 3, p. 34-38 5 p.

  Research output: Contribution to journal › Article › peer-review

• Multiomics Couples Data Generation and Clinical Science

  Liszewski, K., Jun 1 2024, In: Genetic Engineering and Biotechnology News. 44, 6, p. 32-35 4 p.

  Research output: Contribution to journal › Article › peer-review

• Multispecific Antibodies Come to Grips with Manifold Targets

  Liszewski, K., May 1 2024, In: Genetic Engineering and Biotechnology News. 44, 5, p. 44-47 4 p.

  Research output: Contribution to journal › Article › peer-review

• Organoids Stand Out as Stand Ins in Drug Development

  Liszewski, K., Sherman, H., Rocca, D., Brackenbury, L., Dhamija, S. & Ewart, L., Apr 1 2024, In: Genetic Engineering and Biotechnology News. 44, 4, p. 20-23 4 p.

  Research output: Contribution to journal › Article › peer-review

• Phage Therapy’s Neglected Potential Is Finally Being Realized

  Liszewski, K., Sep 1 2024, In: Genetic Engineering and Biotechnology News. 44, 9, p. 54-56 and 58

  Research output: Contribution to journal › Article › peer-review

• RNA Medicines: Address Stability and Deliverability Challenges

  Liszewski, K., Feb 1 2024, In: Genetic Engineering and Biotechnology News. 44, 2, p. 26-29 4 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• To Reverse Aging's Clock, Adjust the Cell's Machinery: Epigenetic, bioelectromic, synaptic, and senolytic interventions could rejuvenate cells and counter the effects of aging

  Liszewski, K., Oct 1 2024, In: Genetic Engineering and Biotechnology News. 44, 10, p. 32-34 and 36

  Research output: Contribution to journal › Article › peer-review
• 2023

  Alternative pathway activation: Ever ancient and ever new

  Liszewski, M. K. & Atkinson, J., Jan 2023, In: Immunological Reviews. 313, 1, p. 60-63 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Cell Damage 100%
  • Disease Process 100%
  • Chronic Disease 100%
  • Complement Activation 100%
  • Alternative Pathway 100%
  10 Scopus citations

• Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46

  Wu, X., Kathryn Liszewski, M., Java, A. & Atkinson, J. P., Sep 30 2023, In: Annals of Blood. 8

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • CD46 100%
  • Complement Regulators 100%
  • Atypical Hemolytic Uremic Syndrome (aHUS) 100%
  • Atypical Hemolytic Uremic Syndrome 100%
  • Complement Regulator 100%

• Charms to Soothe the Savage Microbiome

  Liszewski, K., Jun 1 2023, In: Genetic Engineering and Biotechnology News. 43, 6, p. 20-23 and 26

  Research output: Contribution to journal › Article › peer-review

• Eliminating Blind Spots in Pandemic Preparedness

  Liszewski, K., Jul 1 2023, In: Genetic Engineering and Biotechnology News. 43, 7, p. 16-19 4 p.

  Research output: Contribution to journal › Article › peer-review

• Emerging Infectious Diseases Prompt a Layered Response

  Liszewski, K., Aug 1 2023, In: Genetic Engineering and Biotechnology News. 43, 8, p. 20-23 4 p.

  Research output: Contribution to journal › Article › peer-review

• Liquid Biopsy Technologies Hasten Progress in Precision Oncology

  Liszewski, K., Sep 1 2023, In: Genetic Engineering and Biotechnology News. 43, 9, p. 26-29 4 p.

  Research output: Contribution to journal › Article › peer-review

• Liver pathology in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: vasculopathic disease beyond nodular regenerative hyperplasia

  Khonde, P., Chatterjee, D., Bogacki, M., Liszewski, M. K., Ford, A. L., Miner, J., Atkinson, J. P. & Brunt, E. M., May 2023, In: Human Pathology. 135, p. 22-34 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Leukoencephalopathy 100%
  • Liver Pathology 100%
  • Retinal Vasculitis 100%
  • Systemic Manifestations 100%
  • Nodular Regenerative Hyperplasia 100%
  1 Scopus citations

• mRNA Vaccines and Therapeutics Combine Power and Finesse Platforms for developing mRNA vaccines and therapeutics offer potent payloads, targeted delivery, and durable expression, as well as smooth paths to manufacturing

  Liszewski, K., Nov 1 2023, In: Genetic Engineering and Biotechnology News. 43, 11, p. 18-20 and 22

  Research output: Contribution to journal › Article › peer-review

• Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus

  Liszewski, K., May 1 2023, In: Genetic Engineering and Biotechnology News. 43, 5, p. 16-18 and 20

  Research output: Contribution to journal › Article › peer-review

• Researchers Approach the Epigenetic Gatekeepers of Health and Disease Openings may be found in consolidated genetic/epigenetic sequencing workflows, links between chromatin changes and disease states, and reversible epigenetic changes

  Liszewski, K., Mar 1 2023, In: Genetic Engineering and Biotechnology News. 43, 3, p. 46-48 and 50

  Research output: Contribution to journal › Article › peer-review

• Tripledemic Rouses Vaccine Developers and Variant Trackers

  Liszewski, K., Feb 1 2023, In: Genetic Engineering and Biotechnology News. 43, 2, p. 38-40+42-43

  Research output: Contribution to journal › Article › peer-review
• 2022

  Biocomputing Mining, Modeling and Melding Biological Data

  Liszewski, K., Feb 1 2022, In: Genetic Engineering and Biotechnology News. 42, 2, p. 44-47 4 p.

  Research output: Contribution to journal › Article › peer-review

• Chromatography Displays Bioprocessing's "colors" More Vividly

  Liszewski, K., May 1 2022, In: Genetic Engineering and Biotechnology News. 42, 5, p. 58-60 3 p.

  Research output: Contribution to journal › Article › peer-review

• Complement and Complement Disorders

  Atkinson, J., Liszewski, M. K., Java, A. & Kulkarni, H. S., Jan 1 2022, Clinical Immunology: Principles and Practice, Sixth Edition. Elsevier, p. 506-524 19 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Complement Activation 100%
  • Complement Disorder 100%
  • Complement System 66%
  • Inflammation Response 66%
  • Leukocytes 33%
  1 Scopus citations

• Drug Discovery Picks Up the Pace, Stays on Target

  Liszewski, K., Jan 1 2022, In: Genetic Engineering and Biotechnology News. 42, 1, p. 46-50 5 p.

  Research output: Contribution to journal › Article › peer-review

• Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26)

  Hemsath, J. R., Liaci, A. M., Rubin, J. D., Parrett, B. J., Lu, S. C., Nguyen, T. V., Turner, M. A., Chen, C. Y., Cupelli, K., Reddy, V. S., Stehle, T., Liszewski, M. K., Atkinson, J. P. & Barry, M. A., Feb 2022, In: Journal of virology. 96, 3, e00826-21.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adenovirus 100%
  • Human Adenovirus (HAdV) 100%
  • Receptor Utilization 100%
  • CD46 Receptor 100%
  • Species D 100%
  12 Scopus citations

• From Tiny Samples to Big Findings

  Liszewski, K., Mar 1 2022, In: Genetic Engineering and Biotechnology News. 42, 3, p. 38-40 and 42-43

  Research output: Contribution to journal › Article › peer-review

• New Directions in Cancer Immunotherapy

  Liszewski, K., Jul 1 2022, In: Genetic Engineering and Biotechnology News. 42, 7, p. 44-46 3 p.

  Research output: Contribution to journal › Article › peer-review

• Precision Medicine Marshals Its Resources

  Liszewski, K., Sep 1 2022, In: Genetic Engineering and Biotechnology News. 42, 9, p. 56-58 and 60

  Research output: Contribution to journal › Article › peer-review

• Transforming Psychedelics into Approved Medicines

  Liszewski, K., Oct 1 2022, In: Genetic Engineering and Biotechnology News. 42, 10

  Research output: Contribution to journal › Article › peer-review

• With Cell Therapy Products, Multiple Safety Issues Call for Multiple Solutions

  Liszewski, K., Dec 1 2022, In: Genetic Engineering and Biotechnology News. 42, 12, p. 48-51 4 p.

  Research output: Contribution to journal › Article › peer-review
• 2021

  Dengue and the lectin pathway of the complement system

  Kraivong, R., Punyadee, N., Liszewski, M. K., Atkinson, J. P. & Avirutnan, P., Jul 2021, In: Viruses. 13, 7, 1219.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Complement System 100%
  • Dengue Virus 100%
  • Lectin Pathway 100%
  • Dengue 100%
  • Dengue Fever 100%
  14 Scopus citations

• Extending Biosafety Testing to Gene Therapy Products

  Liszewski, K., Dec 1 2021, In: Genetic Engineering and Biotechnology News. 41, 12, p. 36-38+41

  Research output: Contribution to journal › Article › peer-review

• Gene therapies receive a shot in the Arm

  Liszewski, K., Apr 1 2021, In: Genetic Engineering and Biotechnology News. 41, S2, p. S20-S22

  Research output: Contribution to journal › Article › peer-review

• Good CROs Make Dream Teams, Great CROs Make Dynasties

  Liszewski, K., Jun 1 2021, In: Genetic Engineering and Biotechnology News. 41, 6, p. 48+50 and 51+56

  Research output: Contribution to journal › Article › peer-review

• Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections

  Liszewski, K. & Atkinson, J. P., Oct 2021, In: Current Opinion in Immunology. 72, p. 126-134 9 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • CD46 100%
  • Membrane Cofactor Protein 100%
  • Deficiency State 100%
  • Infectious Agent 100%
  • Receptor 25%
  47 Scopus citations

• Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating disease

  Macaron, G., Khoury, J., Hajj-Ali, R. A., Prayson, R. A., Srivastava, S., Ehlers, J. P., Mamsa, H., Liszewski, M. K., Jen, J. C., Bermel, R. A. & Ontaneda, D., Jul 2021, In: Multiple Sclerosis and Related Disorders. 52, 103015.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  • Leukoencephalopathy 100%
  • Demyelinating Diseases 100%
  • Retinal Vasculitis 100%
  • Systemic Manifestations 100%
  • TREX1 100%
  5 Scopus citations

• Reinforcing the body's defenses against cancer

  Liszewski, K., Mar 1 2021, In: Genetic Engineering and Biotechnology News. 41, S1, p. S4-S6

  Research output: Contribution to journal › Article › peer-review
• 2020

  Ag Biotech poised to start a new green revolution

  Liszewski, K., Oct 1 2020, In: Genetic Engineering and Biotechnology News. 40, 10, p. 58+60 and 62-63

  Research output: Contribution to journal › Article › peer-review

• Cancer Drug Discovery's yes RASzle-Dazzle"

  Liszewski, K., Apr 1 2020, In: Genetic Engineering and Biotechnology News. 40, 4, p. 6 1 p.

  Research output: Contribution to journal › Editorial

• CAR T-Cell Optimization Starts in Production, Extends to Therapy

  Liszewski, K., Sep 1 2020, In: Genetic Engineering and Biotechnology News. 40, 9, p. 6 1 p.

  Research output: Contribution to journal › Editorial

• CD46 and oncologic interactions: Friendly fire against cancer

  Elvington, M., Liszewski, K. & Atkinson, J. P., Dec 2020, In: Antibodies. 9, 4, p. 1-14 14 p., 59.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • CD46 100%
  • Oncologic 100%
  • Friendly Fire 100%
  • Malignant Neoplasm 100%
  • Membrane Cofactor Protein 100%
  33 Scopus citations

• Clinical aspects of the complement system in systemic lupus erythematosus

  Atkinson, J. P., Liszewski, M. K. & Yu, C. Y., Jan 1 2020, Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects. Elsevier, p. 113-122 10 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

  • Complement System 100%
  • Systemic Lupus Erythematosus 100%
  • Clinical Aspects 100%
  • Clinical Feature 100%
  • Etiology 40%
  1 Scopus citations

• DNA Digital Data Whets Its Appetite

  Liszewski, K., May 1 2020, In: Genetic Engineering and Biotechnology News. 40, 5, p. 40-43 4 p.

  Research output: Contribution to journal › Article › peer-review

• Lesion evolution and neurodegeneration in RVCL-S: A monogenic microvasculopathy

  Ford, A. L., Chin, V. W., Fellah, S., Binkley, M. M., Bodin, A. M., Balasetti, V., Taiwo, Y., Kang, P., Lin, D., Jen, J. C., Grand, M. G., Bogacki, M., Liszewski, M. K., Hourcade, D., Chen, Y., Hassenstab, J., Lee, J. M., An, H., Miner, J. J. & Atkinson, J. P., Oct 6 2020, In: Neurology. 95, 14, p. E1918-E1931

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neurodegeneration 100%
  • Monogenic 100%
  • Leukoencephalopathy 100%
  • Retinal Vasculitis 100%
  • Systemic Manifestations 100%
  16 Scopus citations

• The complement system in COVID-19: Friend and foe?

  Java, A., Apicelli, A. J., Kathryn Liszewski, M., Coler-Reilly, A., Atkinson, J. P., Kim, A. H. J. & Kulkarni, H. S., Aug 6 2020, In: JCI Insight. 5, 15, e140711.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Complement System 100%
  • COVID-19 100%
  • Coronavirinae 100%
  • Diseases 100%
  • Coronavirus 100%
  277 Scopus citations

• Viral Safety Testing Keeping the Fly out of the Ointment

  Liszewski, K., Dec 1 2020, In: Genetic Engineering and Biotechnology News. 40, S6, p. S10-S12

  Research output: Contribution to journal › Article › peer-review
• 2019

  A Multimodality Approach to Assessing Factor I Genetic Variants in Atypical Hemolytic Uremic Syndrome

  Java, A., Pozzi, N., Love-Gregory, L. D., Heusel, J. W., Sung, Y. J., Hu, Z., Bertram, P., Liszewski, M. K., Cline, L. M., Ren, Z. & Atkinson, J. P., Jul 2019, In: Kidney International Reports. 4, 7, p. 1007-1017 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  16 Scopus citations

• Complement in motion: The evolution of CD46 from a complement regulator to an orchestrator of normal cell physiology

  Kathryn Liszewski, M. & Kemper, C., 2019, In: Journal of Immunology. 203, 1, p. 3-5 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  27 Scopus citations

• Development and optimization of an ELISA to quantitate C3(H₂O) as a marker of human disease

  Elvington, M., Liszewski, M. K., Liszewski, A. R., Kulkarni, H. S., Hachem, R. R., Mohanakumar, T., Kim, A. H. J. & Atkinson, J. P., 2019, In: Frontiers in immunology. 10, APR, 703.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • ELISA 100%
  • Freeze Thawing 100%
  • Human Disease 100%
  • C3(H2O) 100%
  • Blood Plasma 66%
  13 Scopus citations

• Fledgling Steps toward Regenerative Medicine Superpowers

  Liszewski, K., Aug 2019, In: Genetic Engineering and Biotechnology News. 39, S4, p. S7-S9

  Research output: Contribution to journal › Article › peer-review

• Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice

  Smith-Jackson, K., Yang, Y., Denton, H., Pappworth, I. Y., Cooke, K., Barlow, P. N., Atkinson, J. P., Kathryn Liszewski, M., Pickering, M. C., Kavanagh, D., Terence Cook, H. & Marchbank, K. J., Mar 2019, In: Journal of Clinical Investigation. 129, 3, p. 1061-1075 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Complement Component 3 100%
  • Thrombotic Thrombocytopenic Purpura 100%
  • Thrombotic Microangiopathy 100%
  • Complement C3 100%
  • Atypical Hemolytic Uremic Syndrome (aHUS) 100%
  26 Scopus citations